GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with … – The Pharma Letter

GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with
The Pharma Letter
Asthma (100/25mcg and 200/25mcg): The regular treatment of asthma in adults and adolescents aged 12 years and older, where use of a combination product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate. • COPD (100/25mcg): The
GSK, Theravance seek approvals for FF/VI in US, EuropePharmaceutical Business Review
GSK and Theravance file next-generation Advair in USA, EUPharma Times

all 3 news articles »

View full post on asthma – Google News

SkyePharma’s Asthma Drug Finally Approved in Europe – Equities.com

SkyePharma's Asthma Drug Finally Approved in Europe
Equities.com
LONDON – The asthma treatment Flutiform finally won the seal of the European Commission last week, more than 12 years after SkyePharma plc set its sights on what it thought would be the relatively straightforward development of a combination product
Small caps: Drug OK lifts SkyePharmaFinancial Times

all 2 news articles »

View full post on asthma – Google News

Aptar Pharma celebrates asthma day with a twister™ of innovation – Packaging Europe


Packaging Europe

Aptar Pharma celebrates asthma day with a twister™ of innovation
Packaging Europe
World leader in the development and manufacturing of nasal and pulmonary drug delivery devices including inhalers for asthma, Aptar Pharma launches Twister™, a new versatile affordable capsule-based Dry Powder Inhaler (DPI) specifically targeting fast

View full post on asthma – Google News

Aerocrine appoints Morten Gunvad as VP Commercial Operations Europe and Asia – CisionWire (press release)

Aerocrine appoints Morten Gunvad as VP Commercial Operations Europe and Asia
CisionWire (press release)
I am excited to join Aerocrine and contribute to making the company's products available to a growing number of patients living with asthma.” “Aerocrine is commercially active in numerous European and Asian markets where a significant share of the

and more »

View full post on asthma – Google News